Related posts
S&P, Dow hit records, tech soarsThis summary was created by AI, based on 2 opinions in the last 12 months.
Atrion Corp (ATRI-Q) is a company that manufactures medical supplies, particularly lens cases for contact lenses. The stock has experienced a recent buyout offer at $460, much lower than the estimated value of $600-800 according to one expert. The share price plunged due to high interest rates, impacting customer inventory levels, but the expectation is that orders will resume once existing inventory is depleted. With a low PE ratio of 20x and a 2.5% dividend that has historically been rising, ATRI is seen as a potential value play in the long term, despite the recent challenges. Overall, the company appears to have strong fundamentals and potential for growth.
They make medical supplies, like lens cases for contact lenses. Shares plunged this year due to high interest rates, so their customers didn't buy much from them. But when those customers finish working through their existing inventory, they will order from ATRI again. Trades at only 20x PE, and pay s a 2.5% dividend, which rising 10% annually except this year.
Small caps tend to be less liquid and therefore may have higher betas, although this one is low at 6.1, because it doesn't trade a lot. It makes all kinds of medical devices that none of the big guys want to manufacture. A good entry point would be around $50. This is one you want to hold for the long run.
(A Top Pick Jan 15/16. Up 44.32%.) A tiny little company out of Texas that makes things in the healthcare sector that nobody else wants to create, such as little catheters, IV tubes, cases for contact lenses, etc. His fear is that this company could get bought out because the CEO is getting into his 60s, and succession would be a risk. He wouldn’t buy at this price as it is a little overpriced. Buy on weakness.
(A Top Pick April 4/16. (Actually Jan 15/16.) Up 0.65%.) A little, small medical device company that handles products that larger companies don’t want to be bothered with. It continues to grow very well in the little niches that nobody else wants to do. The dividend has been growing roughly at a 20% clip. Earnings are supposed to be between $15 and $20.
(Top Pick Jan 15/16, Up 10.30%) Small company that makes vascular clamps and pull tags on life vest. Long term growth over the last 15-20 years. No one else makes these clips. They make good margins.
Atrion Corp is a American stock, trading under the symbol ATRI-Q on the NASDAQ (ATRI). It is usually referred to as NASDAQ:ATRI or ATRI-Q
In the last year, 1 stock analyst published opinions about ATRI-Q. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Atrion Corp.
Atrion Corp was recommended as a Top Pick by on . Read the latest stock experts ratings for Atrion Corp.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered Atrion Corp In the last year. It is a trending stock that is worth watching.
On 2024-08-20, Atrion Corp (ATRI-Q) stock closed at a price of $459.975.
Recently, they announced they were being bought out at $460, which angers him between the stock is worth $600-800. He suspects the aging owners just wanted to retire and get out of the business, so they sold.